This report provides forecast and analysis of the cancer immunotherapy market on the global and regional levels. It provides historical data of 2015 along with forecast from 2016 to 2024 in terms of revenue (US$ Mn). The report also includes macroeconomic indicators globally. It includes drivers and restraints of the cancer immunotherapy market and their impact on each region during the forecast period.
Get a Sample of Research Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4312
The report also comprises the study of current issues with end users and opportunities for cancer immunotherapy manufacturers. It also includes value chain analysis with a list of vendors and industry stakeholders at each node in the value chain, pipeline snapshot and cancer epidemiology in every region.
In order to provide users of this report with a comprehensive view of the market, we have included detailed competitiveness analysis and company players with unique selling propositions. The dashboard provides a detailed comparison of cancer immunotherapy manufacturers on parameters such as collective market share and geographic concentration. The study encompasses market attractiveness analysis, by therapy type, by therapeutic area, by end users and region.
The report includes revenue generated from sales of cancer immunotherapy drugs in all regions and important countries in these regions. By therapy type, the global cancer immunotherapy market has been segmented into monoclonal antibodies, immune checkpoint inhibitors which is further classified into PD-1/PD-L1 and CTLA-4, immune system modulators, cancer vaccines and others. By therapeutic area, the market is segmented into lung cancer, colorectal cancer, breast cancer, prostate cancer, melanoma, blood cancer and others.
On the basis of end users, the global cancer immunotherapy market is segmented into hospitals, ASC’s (ambulatory surgical centers), cancer research centers, and clinics. On the basis of region, the market is segmented into North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa.
Market numbers have been estimated based on revenue generated by cancer immunotherapy drugs yearly by therapy type. Market size and forecast for each segment have been provided in the context of global and regional markets. The cancer immunotherapy market has been analyzed based on expected demand. All key end users have been considered, and potential applications have been estimated on the basis of secondary sources and feedback from primary respondents.
Regional demand patterns have been considered while estimating the market for various end users of cancer immunotherapy in different regions. Top-down approach has been used to estimate the cancer immunotherapy market by region. Market numbers for global therapy and therapeutic area segments have been derived using the bottom-up approach, which is cumulative of each region’s demand. The company-level market share has been derived on the basis of revenues reported by key manufacturers. The market has been forecast based on constant currency rates.
A number of primary and secondary sources were consulted during the course of the study. Secondary sources include NCBI, cancerresearch.org, WHO, FDA, Google Books, articles, company annual reports, websites, press releases, and publications.
The report provides detailed competitive dashboard and company profiles of key participants operating in the global market. Some of the key players in the global cancer immunotherapy market includes Amgen, Inc., AstraZenca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F.Hoffmann-La Roche Ltd., GlaxoSmithKline Plc., Janssen Biotech, Inc., Merck & Co., Inc., Novartis AG, Pfizer, Inc., Sanofi, Spectrum Pharmaceuticals, Inc., and Takeda Pharmaceuticals.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453